Citius Oncology, Inc. Common Stock (CTOR) Technical Analysis
$0.92▲0.82%
Market is closed - opens 7 PM, 14 Sep 2026
Insights
- Citius Oncology Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Citius Oncology Inc. stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Citius Oncology Inc. stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Citius Oncology Inc. stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 64.93 | Sell |
Stochastic | 83.37, 85.33 | Sell |
Ultimate Oscillator | 65.01 | Neutral |
Stochastic Relative Strength Index | 84.04, 91.82 | Sell |
Moving Average Convergence Divergence | 0.05, 0.04 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.84 | Buy |
20 | 0.81 | Buy |
50 | 0.72 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.86 | Buy |
20 | 0.82 | Buy |
50 | 0.77 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.88 | Neutral |
20 | 0.83 | Buy |
50 | 0.75 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.91 | Buy |
20 | 0.88 | Buy |
50 | 0.8 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.93 | Buy |
20 | 0.91 | Buy |
50 | 0.85 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 1.02 |
Resistance L2 | 0.98 |
Resistance L1 | 0.94 |
Pivot Point | 0.91 |
Support L1 | 0.87 |
Support L2 | 0.83 |
Support L3 | 0.8 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.